TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT
Systemic mastocytosis (SM) is a rare disease with a range of clinical presentations, and the vast majority of patients have a KIT D816V mutation that results in gain of function. The multikinase/KIT inhibitor midostaurin inhibits the D816V mutant, and has a well-established role in treatment of adv...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
PAGEPress Publications
2022-10-01
|
| Reeks: | Mediterranean Journal of Hematology and Infectious Diseases |
| Onderwerpen: | |
| Online toegang: | http://mjhid.org/index.php/mjhid/article/view/5042 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|